Staar Surgical Co (STAA) is a publicly traded Healthcare sector company. As of May 21, 2026, STAA trades at $33.05 with a market cap of $1.61B and a P/E ratio of -20.39. STAA moved +1.41% today. Year to date, STAA is +38.05%; over the trailing twelve months it is +71.78%. Its 52-week range spans $13.50 to $38.60. Analyst consensus is neutral with an average price target of $28.63. Rallies surfaces STAA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Piper Sandler Lifts Price Target to $33 as Q1 Sales Jump 119.6%: Piper Sandler raised its price target to $33 from $16, reflecting confidence in a rebound as Staar Surgical reported first-quarter net sales of $93.5 million, up 119.6% year-over-year. The company turned an EPS of $0.38 versus a $0.52 loss last year, citing resolved inventory and merger-related issues boosting profitability.
| Metric | Value |
|---|---|
| Price | $33.05 |
| Market Cap | $1.61B |
| P/E Ratio | -20.39 |
| EPS | $-1.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $38.60 |
| 52-Week Low | $13.50 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $239.44M |
| Net Income | $-80.45M |
| Gross Margin | 76.19% |
10 analysts cover STAA: 0 strong buy, 2 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $28.63.